Parkinsonism and movement disorders in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)
Objective: To study and report the frequency of movement disorders in Cerebral Autosomal-Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL). Background: CADASIL is the main…Hyposmia as a predictor of non-motor symptom in patients with de novo Parkinson’s disease
Objective: To evaluate hyposmia as a predictor of non-motor features in patients with early Parkinson's disease (PD). Background: Hyposmia is quite a common finding in…Body weight determinants in Parkinson’s disease: A multifactorial study
Objective: The aim of this study was to investigate the relationship between some of the variables that may influence body weight and the observed body…Depression and anxiety in Parkinson’s disease with rapid eye movement sleep behavior disorder
Objective: To investigate whether rapid eye movement sleep behavior disorder (RBD) is associated with depression or anxiety in patients with Parkinson's disease (PD). Background: RBD…The non-motor side of the honey-moon period of Parkinson’s disease
Objective: To explore the non-motor side of the honey-moon period in Parkinson's disease (PD) and its impact on quality of life (QoL). Background: Although there…P100 latency of pattern reversal visual evoked potential and visual hallucination in Parkinson’s disease
Objective: To investigate whether P100 latency of pattern reversal visual evoked potential (PR-VEP) can predict the development of visual hallucination (VH) in Parkinson's disease (PD).…Impulse control disorders after STN DBS for Parkinson’s disease
Objective: To evaluate the prevalence and severity of impulse control disorders (ICD) and other impulsive-compulsive behaviors (ICB) in a cohort of patients with Parkinson's disease…Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson’s disease. PPMI cohort
Objective: To examine baseline prevalence and longitudinal change in non-motor symptoms (NMS) in a cohort of de novo (at baseline) Parkinson's disease (PD) patients compared…Frequency and factors associated with neuropathic pain in patients with Parkinson’s disease
Objective: To determine the prevalence of neuropathic pain in PD and association between neuropathic pain, duration of PD, treatment with Levodopa, cumulative dose, non-motor symptoms…The National Parkinson Foundation mentoring and networking program: Phase I the process
Objective: The National Parkinson Foundation (NPF) has focused on meeting the needs in the care and treatment of Parkinson's disease (PD). Through the Centers of…
- « Previous Page
- 1
- …
- 156
- 157
- 158
- 159
- 160
- …
- 207
- Next Page »